EBRIGHT GEORGE W 4
4 · NABI BIOPHARMACEUTICALS · Filed Apr 28, 2005
Insider Transaction Report
Form 4
EBRIGHT GEORGE W
Director
Transactions
- Exercise/Conversion
Common Stock
2005-04-26$4.88/sh+7,500$36,563→ 19,825 total - Sale
Common Stock
2005-04-26$11.15/sh−7,500$83,647→ 12,325 total - Exercise/Conversion
Stock Option (right to buy)
2005-04-26−7,500→ 0 totalExercise: $4.88From: 2000-11-26Exp: 2005-05-26→ Common Stock (7,500 underlying)